How to Safely Come Off Risperidone (Risperdal)

Risperidone, sold as Risperdal, is one of the most widely prescribed antipsychotics in the United States. It helps a lot of people. It also has a habit of staying in someone’s medication list years after the reason for starting it has faded. If you have been on it a long time and you are wondering whether you still need it, that is a fair question to ask. The honest answer is that many people can come off risperidone, that doing it well takes months rather than weeks, and that the way you taper matters more than whether you taper at all.

Why do people want to come off risperidone?

People reach this question from very different directions.

Some started risperidone during a crisis. A hospital stay, a severe episode of psychosis, a stretch of agitation that nobody could manage at home. The crisis passed. The prescription did not. Years later nobody is quite sure who is supposed to revisit it.

Some were given it for something it was never meant to treat long term. Risperidone gets used off label for sleep, for anxiety, for irritability, and for behavior changes in dementia. A Canadian clinical practice guideline on deprescribing antipsychotics is direct about this: for adults using an antipsychotic for insomnia, the recommendation is to stop it [3].

Some are bothered by side effects. Risperidone raises prolactin more than most other second generation antipsychotics do, and that can cause missed periods, breast tenderness, milk production, breast growth in men, and sexual problems [8][9]. Weight gain, higher blood sugar, higher cholesterol, stiffness, restlessness, and tardive dyskinesia all show up on the label as things to watch for [8].

And some simply feel flat. Not sick, not well, just muted. That is a real reason to reopen the conversation, and it is one that deserves to be taken seriously rather than brushed aside.

None of those reasons automatically means you should stop. They mean the medication deserves a fresh look. That review is the same one we walk through in how deprescribing works: what is this drug doing for me now, what is it costing me, and what would happen if we lowered it.

What does risperidone actually do in the brain?

Risperidone blocks dopamine D2 receptors. Dopamine is a signaling chemical involved in motivation, movement, and how the brain decides what is important. In psychosis, that signaling appears to run too hot, and blocking some of it can quiet hallucinations and delusions.

The brain does not sit still while this happens. Over months of steady blockade, it compensates. It grows more receptors and makes them more sensitive, which is a normal way the body pushes back against an outside force. Researchers call this dopamine supersensitivity.

That adaptation is the reason stopping suddenly can go badly. Pull the block away all at once and the brain is left with an amplified dopamine system and nothing damping it. The result can be restlessness, insomnia, nausea, and in some cases a return of psychotic symptoms that arrives faster and harder than the original illness ever did [11].

The other thing to understand is that the relationship between dose and receptor blockade is not a straight line. It is a curve that flattens out. Going from 4 mg to 3 mg changes receptor blockade only a little. Going from 1 mg to 0 mg changes it enormously. This single fact explains most of what follows.

Is it safe to stop risperidone? What the research actually shows

This is where honesty matters more than reassurance. The research does not say “stopping is safe.” It says “stopping carries real risk, and that risk is manageable and worth weighing against the risk of staying.”

Here is what the strongest studies found.

In dementia. A trial published in the New England Journal of Medicine followed people with Alzheimer’s disease whose psychosis or agitation had responded to risperidone. Those switched to placebo relapsed 60% of the time in the first 16 weeks, compared with 33% of those who stayed on it [1]. That is close to double. At the same time, a Cochrane review of antipsychotic withdrawal in dementia found that many older adults with milder symptoms come off without any worsening at all [2]. Both things are true. Who you are matters.

In schizophrenia and long term psychosis. A large analysis in The Lancet found that staying on an antipsychotic cut one year relapse rates from 64% to 27% [5]. More recently, the RADAR trial in England randomly assigned people with schizophrenia and similar conditions to a slow, supported dose reduction or to staying put. Over two years, 25% of the reduction group had a severe relapse compared with 13% of those who continued, and social functioning did not improve in the reduction group [6][10].

The long view. A Dutch study followed people after a first episode of psychosis for seven years. Those who had been in an early dose reduction or discontinuation strategy ended up with roughly double the recovery rate of those on maintenance treatment, even though they relapsed more in the first two years [7]. One study is not a verdict, but it is a reminder that the two year picture and the seven year picture can differ.

Put together, the picture is this. If risperidone is treating a serious psychotic illness, stopping raises relapse risk in a way you should plan around carefully, and for some people the right answer is to stay on it or to reduce to a lower dose rather than to zero. If risperidone is treating sleep, anxiety, or behavior in dementia and has been on board for months without a clear ongoing benefit, the case for a careful taper is much stronger.

Why do slow tapers work better than fast ones?

Most taper plans people are handed look like this: cut the dose in half, wait two weeks, cut in half again, stop. It is tidy. It is also the wrong shape.

Because dose and receptor blockade follow a curve rather than a line, equal sized dose cuts do not produce equal sized effects on the brain. A researcher group at King’s College London worked this out in detail and published a tapering method built around it in Schizophrenia Bulletin [4]. Their point is that a taper should aim for even steps in receptor blockade, not even steps in milligrams. In practice that means the cuts get smaller and smaller as the dose gets lower.

They suggest thinking in terms of reducing by a fraction of the current dose, roughly a quarter to a half of whatever you are taking now, and holding each step long enough to see how it goes. For someone who has been on risperidone for years, the intervals between steps are measured in weeks to months, not days [4].

The practical version of this idea is simple enough to say in one sentence. The lower your dose gets, the slower you should go.

We go deeper into the math and the evidence behind this in our guide to hyperbolic tapering, which is written for clinicians but readable if you want the full picture.

What does a risperidone taper look like in practice?

Every plan is individual and belongs to you and your provider. What follows is an illustration of the shape a careful taper takes, not a schedule to follow on your own.

Say someone is on 4 mg a day and has been stable for two years. A cautious plan might move roughly like this:

• 4 mg to 3 mg, hold and watch
• 3 mg to 2 mg, hold and watch
• 2 mg to 1.5 mg
• 1.5 mg to 1 mg
• 1 mg to 0.75 mg
• 0.75 mg to 0.5 mg
• 0.5 mg to 0.25 mg
• 0.25 mg to 0.125 mg, then stop

Notice what happens. The first steps are 1 mg each. The last steps are a fraction of that. The bottom half of the taper takes longer than the top half, and that is by design.

Two practical tools make those small steps possible:

Risperidone oral solution. It comes as 1 mg per mL with a marked syringe, so 0.1 mg steps are easy to measure. This is the single most useful thing to know about tapering risperidone, and many people are never told it exists [8].

The 0.25 mg tablet. Risperidone tablets come in 0.25, 0.5, 1, 2, 3, and 4 mg, so the small sizes are available without any splitting [8].

If you are on the long acting injection, the plan is different. Those forms release the drug slowly over weeks, so the taper is managed by changing the dose or the spacing of injections, and sometimes by switching to the oral form first. That is a conversation for your provider, not something to improvise.

How long does the whole thing take? For someone on a low dose for a short time, weeks may be enough. For someone who has taken risperidone for years at a moderate or high dose, a thoughtful taper often runs six months to well over a year. That sounds slow. It is much faster than restarting after a relapse.

Withdrawal or relapse? How do you tell the difference?

This is the question that decides what happens next, and it gets confused constantly.

Withdrawal effects tend to show up within days of a dose change, involve the body as much as the mind, and settle over days to a few weeks if you hold steady. Common ones include trouble sleeping, nausea, sweating, dizziness, restlessness, anxiety, and new or worsened movements such as twitching or fidgeting [11]. They often improve if you go back up slightly and then move more slowly.

Relapse tends to build over weeks, looks like the symptoms that led to treatment in the first place, and does not settle on its own. Returning voices, returning suspicious thinking, sleep loss driven by racing thoughts rather than by physical restlessness, withdrawal from people, or a slide in self care are the patterns to watch for.

There is an in between category worth naming. Rebound psychosis can appear quickly after a fast reduction and look like relapse, even in people whose underlying illness was well controlled. It is one more argument for going slowly enough that a sudden change is unlikely to be a taper artifact.

The single best defense is a written baseline. Before you start, write down what your normal looks like: hours of sleep, appetite, energy, mood, and any early warning signs you or your family have seen before an episode. Keep a short daily note. When something shifts, you will have something to compare it to instead of relying on memory.

What warning signs mean you should slow down or call?

Agree on these with your provider before the first dose change, so nobody is improvising.

• Hallucinations or suspicious thoughts returning, even mildly
• Two or more nights of little or no sleep
• Family or friends saying you seem different, especially if you do not feel different
• New or worsening movements of the face, tongue, or limbs
• Agitation or aggression that is out of character
• Any thoughts of harming yourself or anyone else

That last one is not a wait and see item. If you are having thoughts of suicide or self harm, call or text 988 in the United States to reach the Suicide and Crisis Lifeline, or go to an emergency department.

Two more rules worth writing down. Do not make a dose change during a major life stress if you can help it, such as a move, a job loss, or a death in the family. And hold your dose steady rather than dropping again if you are still not back to baseline from the last cut.

How do you bring this up with your provider?

Most providers are open to this conversation. What they need is a reason and a plan, not just a request.

Try opening with something concrete. “I have been on risperidone for six years for something that started as an emergency. I would like to talk about whether the dose is still right, and whether a slow reduction makes sense.” That is very different from “I want off this.”

Bring three things to the appointment:

1. Your history. Why you started, how many episodes you have had, what happened the last time the dose changed, and how long you have been stable.
2. Your reason. A specific side effect, a specific goal, or a specific question about whether the drug is still needed.
3. Your support. Who will notice if something changes, and how often you can check in.

Ask for the reduction to be written down with dates and doses, and ask what to do if a step goes badly. A plan that includes “and here is how we pause or go back up” is a good plan. A plan with no reverse gear is not.

If your provider is not comfortable supervising a taper, that is worth respecting rather than fighting. You can ask for a referral, or you can find a clinician who works in deprescribing. Our deprescribing playbook walks through how to prepare for that first appointment.

If you are supporting someone with dementia who is on risperidone, the questions are similar but the decision maker is often a family member. Our guide to antipsychotics in dementia covers that situation in more depth. For a broader look at this drug class, see how to safely come off antipsychotics.

Frequently asked questions